Transcriptomic phenotyping offers mechanistic insight into adipocyte biology and metabolic disease. A signature of adipocyte ...
Glioblastoma (GBM) is an aggressive type of brain cancer that is known to be very difficult to treat. One reason why this ...
Opinion
Pharmaceutical Technology on MSNOpinion
Advancing single-cell transcriptomics into the mainstream of biomedical research
Kelly Parliament, staff application scientist at Beckman Coulter Life Sciences, discusses how automation is improving the efficiency of single-cell transcriptomic workflows.
Researchers demonstrate improved spatial mapping technology that enhances transcript detection, identifies key tumor cell ...
Macrophages, key regulators of tissue health and immune defense, are among the most abundant immune cells in solid tumors. Their role in cancer has been difficult to define because even closely ...
VIB-VUB researchers have developed a patient-relevant lung adenocarcinoma model combined with SEPARATE-Seq technology to ...
The advent of single-cell omics technologies has revolutionized our understanding of the complex cellular landscape in cancer. Traditional bulk sequencing ...
Takara Bio USA, Inc. today announced the launch of its CSP Program and announced the certification of Admera Health on the ...
Cancer tumorigenesis is fundamentally driven by the profound dysregulation of gene regulatory networks (GRNs) and complex epigenetic alterations. With the ...
Human systems immunology is using multi-omics, single-cell tools, spatial technologies, and AI to decode immune responses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results